Ariad Pharmaceuticals Inc Watch

from 10-K 2 pages Amendment No. 7 to Credit Agreement

from 8-K 4 pages Amendment No. 6 to Credit Agreement

from 10-K 3 pages Waiver and Amendment No. 5 to Credit Agreement

from 10-Q 6 pages Waiver and Amendment No. 4 to Credit Agreement

from 10-K 2 pages For Value Received, the Undersigned, Ariad Pharmaceuticals, Inc., a Delaware Corporation, Ariad Corporation, a Delaware Corporation, and Ariad Gene Therapeutics, Inc., a Delaware Corporation (Hereinafter Sometimes Referred to Collectively as the “Borrowers and Each Singly as a Borrower”), Hereby Unconditionally Promises to Pay to the Order of Citizens Bank of Massachusetts, a Massachusetts Bank (The “Lender”) at the Office of the Lender, Located at 28 State Street, Boston, Massachusetts 02109 (Or Such Other Place as the Holder Hereof May Specify in Writing), in Lawful Money of the United States of America and in Immediately Available Funds, the Principal Amount of Nine Million Five Hundred Seventy-Five Thousand and 00/100 Dollars ($9,575,000.00) (The “Loan”). the Borrowers Jointly and Severally Agree to Pay the Principal Amount of the Loan in the Amounts and on the Dates Specified in Subsection 2.5 of the Credit Agreement Dated March 12, 2003, as Amended by Amendment No. 1 to Credit Agreement, Dated December 31, 2003, as Further Amended by Amendment No. 2 to Credit Agreement, Dated December 31, 2004 (As the Same May Be Further Amended, Modified, Supplemented, Extended or Restated From Time to Time, the “Credit Agreement”) by and Between the Lender and the Borrowers. the Borrowers Further Agree to Pay Interest on the Unpaid Principal Balance of the Loan From Time to Time Outstanding From the Closing Date Until Paid, at the Rates and at the Times Provided in the Credit Agreement

from 10-K 11 pages (A) Subject to the Terms and Conditions Hereof, the Lender Agrees to Make a Loan (The “Loan”) to the Borrowers on the Closing Date in the Principal Amount of Nine Million Five Hundred Seventy-Five Thousand and 00/100 Dollars ($9,575,000.00). the Principal Amount of the Loan May From Time to Time Be Advanced as or Converted to (I) Libor Loans, (II) Prime Rate Loans or (III) a Combination Thereof, as Determined by the Borrowers and Notified to the Lender in Accordance With Subsections 2.2 and 2.8. 2. Amendment to Subsection 2.5. Subsection 2.5 of the Credit Agreement Is Hereby Deleted in Its Entirety and Replaced With the Following

from 10-K ~5 pages Ex-10.57 Amendment No. 1 to Credit Agreement

from 10-Q ~50 pages Ex-10.1 Credit Agreement

from 10-Q ~5 pages Ex-10.1 Amendment to Loan and Security Agreement

from 10-K405 ~10 pages Ex-10.49 Amendment to Loan & Security Agreement

from 10-Q ~10 pages Fourth Amendment to Loan and Security Agreement